FDA Releases Guidance on FDA, OHRP Reviews of IRB-Ineligible Pediatric Research
May 2, 2023
The FDA has issued draft guidance outlining the process for FDA/Office for Human Research Protections (OHRP) reviews of pediatric trials that are ineligible for IRB review and approval.
